---
annotations:
- id: PW:0000375
  parent: regulatory pathway
  type: Pathway Ontology
  value: phase I biotransformation pathway via cytochrome P450
- id: PW:0002536
  parent: drug pathway
  type: Pathway Ontology
  value: lidocaine drug pathway
- id: PW:0000754
  parent: drug pathway
  type: Pathway Ontology
  value: drug pathway
- id: PW:0001229
  parent: classic metabolic pathway
  type: Pathway Ontology
  value: xenobiotic metabolic pathway
authors:
- Mkutmon
- DeSl
- MaintBot
description: Lidocaine is primarily metabolized by CYP1A2 but minor involvement of
  CYP3A4 is observed too. Lidocaine, also known as xylocaine and lignocaine is a medication
  used to numb tissue in a specific area.
last-edited: 2019-08-16
organisms:
- Bos taurus
redirect_from:
- /index.php/Pathway:WP3254
- /instance/WP3254
- /instance/WP3254_r106002
revision: r106002
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3254.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Lidocaine is primarily metabolized by CYP1A2 but minor involvement
    of CYP3A4 is observed too. Lidocaine, also known as xylocaine and lignocaine is
    a medication used to numb tissue in a specific area.
  keywords:
  - 2,6-xylidine
  - 2-amino-3-methylbenzoate
  - 3-hydroxylidocaine
  - 3-hydroxymonoethylglycinexylidide
  - 4-hydroxy-2,6-dimethylaniline
  - CYP1A2
  - CYP3A4
  - Lidocaine
  - glycinexylidide
  - monoethylglycinexylidide
  license: CC0
  name: Lidocaine metabolism
seo: CreativeWork
title: Lidocaine metabolism
wpid: WP3254
---